Investment Rating - The report assigns an "Accumulate" rating for the company, indicating a positive outlook for its stock performance in the near term [6]. Core Insights - The company is expanding its presence in the medical aesthetics sector, with a focus on integrating cosmetic and medical products. Recent approvals for differentiated injection products highlight the company's strategic foresight in selecting investment targets [2][6]. - The main brand, Winona, has shown improvement in its performance, particularly during the 2025 Double Eleven shopping festival, where it ranked 8th in the beauty category on Tmall, reflecting a slight increase from the previous year [2]. - The company has made significant investments in various medical aesthetic ventures, including a recent investment in Yizheng Biotechnology and ongoing collaborations with Weimai Medical to explore innovative perioperative skin care solutions [2]. Financial Summary - The company’s market capitalization is approximately 19.87 billion yuan, with a circulating market value of the same amount. The stock has seen a 52-week high of 50.85 yuan and a low of 39.34 yuan, with a price-to-earnings (P/E) ratio ranging from 32.78 to 42.38 [5]. - Profit forecasts indicate a net profit attributable to the parent company of 5.3 billion yuan in 2025, with expected growth rates of 6.3%, 24.7%, and 15.5% for the years 2025, 2026, and 2027 respectively [6][7].

【事项】 公 司 研 究 / 美 容 护 理 / 证 券 研 究 报 告 贝泰妮（300957）动态点评 主品牌表现逐步改善，持续延伸医美领 域布局，关注经营向好趋势 2026 年 02 月 25 日 成都伊臻生物科技有限公司旗下"注射用聚左旋乳酸填充剂"，于 26 年 1 月获批 III 类医疗器械注册证，为全球首个明确获批用于颞部填充 适应症的聚左旋乳酸产品，亦为我国在该部位的首次批准，贝泰妮持 有成都伊臻生物母公司伊正（苏州）生物科技 15.73%股权，为其重要 战略投资者、单体最大股东。 【评论】 公司于医美领域布局不断丰富，有助于深化"妆械联合"逻辑。公司 于 2023 年投资伊正生物，当前差异化的注射剂产品获批亦体现了公 司前瞻布局筛选标的的能力，除医美注射剂外，公司在医美光电赛道 同样有较多布局，如：2023、2024 年，两度投资威脉医疗，旗下核心 射频抗衰产品 YOUMAGIC 舒立缇已经于 2024 年获批，贝泰妮已经 开始联合威脉开始探索围术期皮肤护理的创新性解决办法；2025 年投 资专注于高端医美光电设备研发的苏州紫菘医疗科技。公司在医美注 射剂、光电设备的投资布局不断完善，未来亦可 ...

Summary of Conference Call Notes Company Overview - The focus is on Beitaini, a company in the beauty and personal care industry, which has recently seen a significant stock price increase of 18.9% since January 14, 2023, following a recommendation from the research team [1] Key Points and Arguments - **Market Recognition**: Initially, the market was uncertain about the valuation of Beitaini, but it has gradually recognized the potential for a bottom reversal in the beauty sector, shifting from skepticism to seeking more investment opportunities in beauty brands [1] - **Target Valuation**: The projected target price for Beitaini in 2026 is set at 300 billion, indicating a potential upside of over 40% from the current levels [1] - **Revenue Breakdown**: The revenue estimation is based on three main components: 1. Main brand net profit margin improvement contributing 200 billion 2. Sub-brands expected to generate 50 billion 3. Medical beauty options contributing another 50 billion [1] Additional Insights - **Main Brand Focus**: The current year is seen as foundational for the main brand, with a focus on profit margin recovery. Key observation points for financial performance are set for April, August, and October [2] - **Sub-brands Contribution**: Sub-brands are anticipated to be the primary driver of revenue growth this year, with a significant contribution to market capitalization [3][4] - **High-frequency Data**: High-frequency data from sub-brands is considered more critical for stock price movement compared to the main brand [4] - **Medical Aesthetics Market**: The timing for entering the medical aesthetics market is suggested to align with the approval timeline of similar companies, such as Lepu, and their subsequent sales performance [5] - **Shareholding Changes**: Red Shirt's recent share reduction is expected to be completed soon, which may alleviate market concerns and be interpreted as a positive signal [5] - **Long-term Outlook**: The research team maintains a positive outlook on Beitaini as one of their core recommendations for 2026, emphasizing the company's potential for success [6]

Investment Rating - The investment rating for the company is "Accumulate" [5] Core Insights - The company is expected to implement a product focus and stable pricing strategy in 2025, leading to improved gross margins in the first three quarters. The main brand shows strong resilience, while the sub-brand Aikeman is experiencing breakthroughs, indicating a positive outlook for multi-brand growth to restore the company's growth momentum [2][11] - The forecast for EPS has been raised for 2025-2027 to 1.23 (+0.13), 1.56 (+0.08), and 1.90 (+0.18) yuan, respectively. A target PE of 38x for 2026 has been set, resulting in an updated target price of 59.28 yuan [11] Financial Summary - Total revenue is projected to be 5,522 million yuan in 2023, increasing to 5,736 million yuan in 2024, but decreasing to 5,479 million yuan in 2025, before rising to 6,059 million yuan in 2026 and 6,663 million yuan in 2027 [4] - Net profit attributable to the parent company is expected to decline from 757 million yuan in 2023 to 503 million yuan in 2024, with a slight recovery to 520 million yuan in 2025, and further increases to 663 million yuan in 2026 and 806 million yuan in 2027 [4] - The gross margin for the first three quarters of 2025 improved to 74.33%, a year-on-year increase of 0.6 percentage points [11] Market Performance - The company's stock price has ranged between 39.34 and 50.85 yuan over the past 52 weeks, with a total market capitalization of 20,138 million yuan [6] - The stock has shown an absolute increase of 17% over the past month, 13% over the past three months, and 18% over the past year [10] Brand Performance - The main brand, Winona, has streamlined its product series and focused on core products, achieving a ranking of 9th in the Tmall beauty industry during the Double Eleven shopping festival, maintaining its position in the top 10 for nine consecutive years [11] - The sub-brand Aikeman has seen significant growth, ranking 2nd in the Tmall beauty new brand transaction list during Double Eleven 2025, with key products achieving sales of over 100,000 units [11]

Core Insights - The beauty and personal care industry is experiencing significant development opportunities, with companies expanding internationally and making key advancements in innovative drug research [1] - Huolong Securities maintains a "recommended" rating for the beauty and personal care industry, highlighting the overall shift towards high-quality development [1] - Betaini Group's core brand, Winona, has successfully entered the Middle Eastern market, becoming the first Chinese functional skincare brand registered in Qatar, marking a new phase in the internationalization strategy of Chinese beauty brands [1] Group 1 - Winona opened its first offline store in Doha Mall, Qatar, representing a geographical expansion of the brand [1] - The opening ceremony was attended by prominent figures from the local healthcare and retail sectors, showcasing Winona's professional strength and international influence in the functional skincare field [2] - The successful entry into Qatar is attributed to Betaini's systematic compliance capabilities driven by independent research and development, as well as high-quality product formulations validated by extensive clinical trials [2] Group 2 - Betaini has stated that it is continuously improving its global channel network, with its brands operating locally in Southeast Asia, the Middle East, North America, and Europe [3] - The company emphasizes a cautious and pragmatic approach to international expansion, based on in-depth insights into different regional markets [3] - Future expansion plans will be disclosed through official company communications, ensuring transparency in the progress of specific country or region developments [3]

Group 1 - The beauty care sector is experiencing a surge, with companies like Lafang Jiahua hitting the daily limit up, Jin Sanjiang rising over 10%, and others like Beitaini and Babi shares also showing significant gains [1][2] - Men's skincare products are becoming increasingly popular among Generation Z, with brands like C Coffee and Gu Yu seeing sales growth of 1900% and 1000% respectively during the recent holiday season [1] - Shanghai is focusing on consumer upgrades and market innovation, with plans to enhance domestic brands and improve inbound consumer services by 2026 [2][3] Group 2 - The beauty raw materials sector is witnessing a rapid increase in demand for specialized ingredients tailored to Chinese skin types, benefiting companies with core R&D capabilities [4] - Domestic beauty brands are gaining recognition and are expected to continue growing, especially those with innovative products and multi-channel operations [4] - The demand for cosmetic testing services is rising due to stricter regulations and consumer focus on product efficacy, creating opportunities for companies with advanced technical capabilities [5] Group 3 - Lafang Jiahua is a well-established beauty company focusing on hair care and skincare, actively pursuing brand rejuvenation and increasing R&D investments [6] - Huaxi Biological is a leading biotech firm specializing in hyaluronic acid, benefiting from the trend of domestic raw material production and industry upgrades [6] - Porlaia is a top domestic beauty brand known for effective skincare products, expected to increase R&D investments and expand its market leadership [6] - Beitaini specializes in sensitive skin care and has gained market recognition through collaborations with dermatological institutions, poised to benefit from the growing efficacy skincare market [6]

Core Viewpoint - Betaini (300957) is in the early stages of market introduction and localization operations for its brands, such as Winona, in emerging markets like the Middle East, and the company expresses confidence in the long-term development of overseas markets [1] Group 1 - The company is steadily advancing foundational work, including market education and channel development, to provide professional skincare solutions for sensitive skin to local consumers [1] - Specific market performance and financial data will be disclosed in the company's upcoming periodic reports [1]

Core Viewpoint - The company expresses confidence in the long-term development of its brands, such as Winona and Pomei, in emerging markets like the Middle East, emphasizing a focus on market education and channel development [2]. Group 1: Market Performance - The brands Winona and Pomei are currently in the early stages of market introduction and localization in the Middle East [2]. - The company is committed to providing professional skincare solutions for sensitive skin to local consumers [2]. Group 2: Strategic Focus - The company is steadily advancing foundational work, including market education and channel construction, to support its overseas market initiatives [2]. - Investors are encouraged to monitor the company's upcoming periodic reports for specific market performance and financial data [2].

Core Viewpoint - The company is in the early stages of market introduction and localization for its brands, such as Winona and Pomei, in emerging markets like the Middle East, and expresses confidence in long-term development [1] Group 1 - The company is currently focusing on market education and channel development as part of its foundational work in new markets [1] - The company aims to provide professional skincare solutions for sensitive skin to local consumers [1] - Specific market performance and financial data will be disclosed in future periodic reports [1]

Summary of Key Points from the Conference Call Records Industry Overview - The records focus on the cosmetics industry in China, specifically analyzing the Gross Merchandise Value (GMV) of various brands in January 2026 through data from the Douyin platform. Key Companies and Their Performance 1. 上美股份 (Shangmei Group) - Total GMV for 韩束 (Hansu) and its sub-brands in January was approximately 6.6 billion CNY, representing a 9% increase year-over-year [1] - 韩束 brand GMV was about 5.3 billion CNY, showing a decline of 3% [1] - NewPage brand GMV reached approximately 0.7 billion CNY, marking a significant increase of 120% [1] - 极方 (Jifang) achieved a GMV of 0.1 billion CNY, with rapid growth year-over-year [1] - 聚光白 (Juguangbai) also recorded a GMV of 0.1 billion CNY, indicating high growth [1] - 安敏优 (Anminyou) had a GMV of 0.3 billion CNY, with a remarkable year-over-year growth of 267% [1] 2. 珀莱雅 (Proya) - The three major brands under Proya had a combined GMV of 3.5 billion CNY in January, reflecting a 2% increase [1] - The main brand, 珀莱雅, generated a GMV of approximately 2.8 billion CNY, down by 2% [1] - 彩棠 (Caitang) brand GMV was 0.3 billion CNY, showing a decline of 12% [1] - OR洗护 (OR Hair Care) brand GMV reached 0.3 billion CNY, with a substantial increase of 148% [1] 3. 若羽臣 (Ruoyuchen) - The combined GMV for the brands 绽家 (Zhanjia), 斐萃 (Feicui), and Nuibay was 1.7 billion CNY [2] - 绽家 brand GMV was 0.7 billion CNY, increasing by 88% [2] - 斐萃 brand GMV was 0.8 billion CNY, showing a remarkable growth of 345% [2] 4. 丸美股份 (Marubi) - The total GMV for its two main brands was 2.6 billion CNY, reflecting a 1% increase [2] - 主品牌丸美 (Marubi) had a GMV of approximately 1.8 billion CNY, up by 5% [2] - 恋火 (Lianhuo) brand GMV was 0.8 billion CNY, down by 7% [2] 5. 毛戈平 (Mao Geping) - The brand achieved a GMV of approximately 2.9 billion CNY, with an increase of 78% [2] 6. 林清轩 (Lin Qingxuan) - The brand's GMV was 2.6 billion CNY, reflecting a significant increase of 145% [2] 7. 薇诺娜 (Winona) - The brand recorded a GMV of 1.0 billion CNY, with a growth of 156% [2] 8. 润本 (Runben) - The brand's GMV was approximately 0.4 billion CNY, showing a slight decline of 1% [2] 9. 福瑞达 (Furuida) - The two major brands under Furuida had a combined GMV of about 0.8 billion CNY, increasing by 12% [2] 10. 水羊股份 (Shuiyang) - The four major brands achieved a GMV of approximately 0.7 billion CNY, doubling year-over-year [2] 11. 上海家化 (Shanghai Jahwa) - The three skincare brands under Shanghai Jahwa had a combined GMV of about 0.9 billion CNY, reflecting a significant increase of 252% [2] 12. 植物医生 (Plant Doctor) - The brand's GMV in December was 0.1 billion CNY, showing a decline of 5% [2] 13. 拉芳 (Lafang) - The brand achieved a GMV of approximately 0.1 billion CNY, with an increase of 135% [2] Additional Insights - The data indicates a mixed performance across various brands, with some experiencing significant growth while others faced declines. - The overall trend suggests a competitive landscape in the cosmetics industry, with emerging brands showing strong growth potential, particularly in the Douyin channel. This analysis highlights the dynamic nature of the cosmetics market in China, emphasizing the importance of monitoring GMV trends for investment opportunities and risk assessment.